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BACKGROUND: ABO dependent variation in von
Willebrand factor (vWF) and factor VIII have an impact on hemostasis. Several contradictory studies have investigated the influence of ABO blood type in surgical hemorrhage. Emergency surgery is associated with an increased risk of perioperative hemorrhage leading to inferior clinical outcomes. The aim of this study was to investigate if patients with blood type O received more transfusions with blood components compared with non-O patients after major emergency abdominal surgery.
STUDY DESIGN AND METHODS: This retrospective
observational study combined perioperative data including hemoglobin with transfusion data in patients undergoing emergency surgery at a university hospital between January 2010 and October 2016. The primary outcome was postoperative transfusion stratified into early transfusion, within 24 hours after surgery, and late transfusion from 24 hours to 7 days (POD7) after surgery.
RESULTS:
A total of 869 patients were included, 363 patients with blood type O (42.0%) and 501 (58.0%) with blood type non-O. We found no difference in the need for transfusion with 42 (11.6%) patients with blood type O and 66 (13.2%) patients with blood type non-O receiving early transfusion and 39 (13.4%) and 48 (11.9%) of O and non-O patients, respectively, receiving late transfusion. Multivariate logistic regression analysis showed an adjusted OR of 0.915 (95% CI 0.569-1.471) for early transfusion and an adjusted OR of 1.307 (95% CI 0.788-2.169) for late transfusion in patients with blood type O. Likewise, no difference was seen with respect to the change in hemoglobin levels before and after surgery as well as transfused volume.
CONCLUSION:
We did not find an association between transfusion or perioperative changes in hemoglobin with respect to blood type ABO. E mergency surgery is associated with an increased risk of perioperative hemorrhage and shows inferior morbidity and mortality outcomes compared with elective surgery. 1 Blood transfusion of any type of component is a risk factor for all-cause mortality in emergency surgery and has been suggested among the leading causative factors for the aggravation of outcomes in emergency surgery. 1 Patients with blood type O (type O) have 15-25% less von Willebrand Factor (vWF) and a decreased activity of factor VIII compared with blood type non-O (type non-O). [2] [3] [4] vWF is important for primary hemostasis, ensuring the adhesion of platelets to the subendothelium of damaged blood vessels and promoting aggregation. Furthermore, it acts as a carrierprotein for factor VIII and protects it from proteolysis.
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Patients with type O have a prolonged bleeding time, [6] [7] [8] a greater tendency of mucocutaneous bleeding, 9,10 and less risk of developing deep venous thromboses.
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Earlier studies on hemorrhage and transfusion in relation to blood type have been contradictory. A meta-analysis of surgical and non-surgical patients showed a significant increase in hemorrhage in patients with type O compared with non-O, 12 whereas there is contradictory results both for 13, 14 and against [15] [16] [17] an increased need for transfusion in relation to surgery in patients with type O. Recently, an increased mortality due to trauma induced hemorrhage was reported in patients with type O. 18 The impact of ABO blood type on perioperative transfusion has however, not previously been investigated in major emergency abdominal surgery. The aim of this study was to investigate the transfusion requirements in patients with blood type O vs. non-O, hypothesizing that patients with blood type O would be more likely to experience peri-and postoperative transfusion compared with non-O patients after major emergency abdominal surgery.
MATERIALS AND METHODS
Study design and setting
We did a retrospective cohort study reported according to the REporting of studies Conducted using Observational Routinely-collected Data (RECORD)-checklist, which is an extension to the existing STROBE-guidelines. 19 To investigate the association between ABO-blood type and transfusion, we included all primary major emergency general surgical procedures from January 2010 through September 2016 at a major university hospital (Zealand University Hospital). The study was approved by the Danish Data Protection Agency (approval: REG-010-2017) and did not need approval from an ethics committee according to Danish law. Authors had full access to all data.
Study population
Patients from the age of 18 operated on within 72 hours of admission were included. Surgical procedures included those for small bowel obstruction, colonic obstruction, stomach or bowel perforation, persistent GI-bleeding requiring emergency surgery (not endoscopy), abdominal fascial rupture, intraabdominal abscess requiring surgical intervention, or strangulated hernia in need of bowel resection. Both laparoscopic and open procedures were included. Acute reoperations were also included if adherent to above-mentioned criteria. Patients who underwent several procedures were eligible for inclusion if the primary procedure was includable.
Patients admitted due to trauma, or with pre-existing hematological cancer or inherited bleeding or thromboembolic disorders were excluded from the analysis. Additionally, we excluded patients with an upper GI surgical procedure since these patients often bleed substantially prior to surgery hereby masking surgical bleeding. Patients with preoperative anticoagulant and antiplatelet treatment, i.e., warfarin, anti-FIIa drugs, anti-FXa-drugs, ADP-receptor inhibitors, and acetylsalicylic acid were excluded.
Furthermore, in an effort to omit patients with anemia due to other reasons than surgical bleeding, we excluded patients who received a pre-operative transfusion, at the same time having a hemoglobin under the Danish national upper transfusion limit of 5.6 mmol/L (9.02 g/dL). 20 In a subpopulation, we excluded patients that were re-operated within the first seven post-operative days, as we investigated transfusion within the late postoperative period.
Data collection
We retrospectively included patients based on NOMESCObased procedure codes (Appendix A). The following data were collected from digital medical records: Pre-, intra-, and postoperative data, information on patient demographics, ASA, Charlson Comorbidity Index (CCI), 21 and biochemical data. Preoperative hemoglobin was defined as the first recorded value after admission to hospital prior to surgery. If not available, we evaluated the first measurement within seven preoperative days in an effort to recognize patients with pre-operative anemia. Post-operative hemoglobin was defined as the first measurement within 72 hours of surgery. Transfusion-history and data, as specific volume or number of units of red blood cells (RBC), pools of platelets comprising buffy coat platelets from 4 donors in platelet additive solution (PLT), and fresh frozen plasma (FFP), were available from the regional blood bank software (CSAM ProSang). One RBC, PLT, and FFP unit consist of approximately 250 mL, 350 mL and 250-300 mL, respectively. Patient blood type O, A, B, AB, and Rhesus type were collected from electronic blood bank records. We also collected data on reoperation. Unique personal identifier (CRS number) was used as an inter-source link. The CRS number is a personal identifier, which enables accurate record linkage across all national Danish registers.
Outcomes
The primary outcome was any type of postoperative transfusion (RBC, PLT, FFP) following major emergency abdominal surgery. This was stratified into early transfusion, i.e., transfusion within 24 hours of surgery; and late transfusion i.e., from 24 hours to 7 days after surgery. The population was separated into adequate groups, with the "late" group excluding patients re-operated on within seven postoperative days, besides the other exclusion criteria.
The secondary outcome was change in hemoglobin from the level prior to surgery to the level immediately after surgery. Furthermore, we investigated the volume and units of administered blood components.
Though no international consensus exists, the Danish national guideline suggests that patients are transfused if they have hemoglobin below an upper limit of 4.3 mmol/L (6.9 g/ dL), 5.0 mmol/L (8 g/dL) if suffering from chronic heart failure, or 5.6 mmol/L (9.0 g/dL) if suffering from acute coronary syndrome, or if symptomatic of acute anemia. 20 
Statistical analysis
We stratified the population into type O and type non-O. Categorical data are presented as proportions (%). Continuous data were examined for normal distribution by visual assessment of QQ-plots and histograms and presented as means with standard deviation (SD) and medians with interquartile range (IQR). In the unadjusted analysis, continuous outcomes were compared using student ' 
RESULTS
In the study period, 1,288 potentially eligible patients underwent surgery. We included 864 emergency surgical patients in the analysis of early transfusion as presented in Fig. 1. Of these, 363 patients were type O (42.0%) and 501 (58.0%) were type non-O (A, B, AB). A total of 170 patients were re-operated within the first 7 days and thereby excluded from the late transfusion analysis group. Baseline patient characteristics are presented in Table 1 . No differences were seen between the blood type groups. Table 2 presents a comparison of transfusion characteristics stratified on blood type within the first 24 post-surgical hours. No difference between groups was seen with respect to any blood component with a total of 42 (11.6%) patients with type O and 66 (13.2%) patients with type non-O receiving a transfusion of any kind (p = 0.48). Table 2 also shows a comparison of the late period transfusion, where 39 (13.4%) patients with type O and 48 (11.9%) non-O patients received a transfusion of any kind. No differences were seen with respect to transfusion of different blood components.
In Table 3 , the changes in hemoglobin before and after surgical intervention are presented. The mean hemoglobin decrease was similar in the two groups with type O patients having a reduction of 1.4 (SD 1.0) mmol/L (2.2 g/dL SD1.7 g/dL), while hemoglobin in non-O patients fell 1.4 (SD1.0) mmol/L (2.2 g/dL SD1.7 g/dL), p = 0.744. The relative change in hemoglobin, with respect to hemoglobin at admission was 0.16 (SD0.11) for patients with type O and 0.15 (SD0.12) for type non-O.
A comparison of the volume of transfusion of different components is presented in Table 4 . No significant differences were seen between the blood type groups. Figure 2 shows the number of units transfused per patient in the first 7 postoperative days stratified on blood type. No significant differences were seen between the number of transfusions at each postoperative day for type O versus non-O.
Several factors were significantly associated with the risk of early transfusion of any type (Appendix B) including ASA-score > 2 (p = .001), age (p = .016), CCI (p = .004), and excess alcohol usage (p = .025). Neither ABO blood type, gender, BMI, or smoking influenced the risk of an early transfusion. An identical pattern was observed with respect to the risk of a late transfusion (Appendix C).
After adjusting for type of operation, age, ASA > 2 and CCI, type O was not associated with the risk of an early transfusion (adjusted OR 0.915 (95% CI 0.57-1.47); p = .714) or a late transfusion (OR 1.307 (95% CI 0.79-2.17); p = 0.30) (Table 5) .
Secondarily, the ratio of transfused components is presented in Table 6 . The number of patients receiving more Abbreviations: ASA = American Society of Anaesthesiology physical status classification system; BMI = body mass index; CCI = Charlson comorbidity index; GI = gastrointestinal; NOAC = novel oral anticoagulants; SD = standard derivation; TRC = antiplatelet drugs. Official recommendations for alcohol consumption are < 7 units/week for women, < 14 units/week for men (1 unit = 12 grams of alcohol).
than one type of blood component was low. No difference was found between type O and type non-O between the early and late ratios. Across both groups, a higher FFP/RBC-and PLT/RBC-ratio was transfused in the late post-surgical stage. A subgroup of the patients was transfused with more than the median transfusion volume of 972.5 mL. A total of 40 (11.0%) patients with type O and 52 (10.0%) patients with type non-O were identified (p = .62). In these patients, the mean transfused volume was 2319 mL (SD1447 mL) in type O patients and 2650 mL (SD2331 mL) in non-O. With respect to the changes in hemoglobin in this subgroup, no differences were observed as type O patients displayed a decline of 1.82 mmoL/L (SD 1.48) (2.93 g/dL SD 2.38) compared to 
DISCUSSION
The aim of this study was to evaluate if blood type O versus blood type non-O was associated with the risk of transfusion after major emergency abdominal surgery. The study showed no difference in postoperative transfusion between patients with type O versus non-O. Furthermore, we found no difference between blood group O vs. non-O with respect to type of blood component transfused, early or late post-surgical transfusion requirement, or change in hemoglobin levels before and after surgery. Finally, among the patients receiving the largest transfusion volume and patients with the largest perioperative drop in hemoglobin, no difference in transfusion requirements was observed between type O and non-O patients. Abbreviations: RBC = unit of red blood cells; PLT = platelets; FFP = unit of fresh frozen plasma; * = late study population. Abbreviations: FFP = unit of fresh frozen plasma; PLT = platelets; RBC = unit of red blood cells.
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O VERSUS NON-O BLOOD TYPE AND TRANSFUSION
This is the first study to investigate the association between transfusion and type O versus non-O in emergency abdominal surgery. ABO type is known to correlate with the levels of vWF as type non-O patients have 25% higher levels of vWF compared to type O patients . [2] [3] [4] Plasma vWF levels are critical for primary hemostasis and is induced by acute inflammation, 22 which could play a role in major emergency abdominal surgery, where patients are subject to a massive systemic inflammation. 23 This possible inflammationinduced increment in vWF could be of clinical significance, and possibly explain the absence of a difference in transfusion requirements between type O and non-O.
Previous findings are contradictory with regard to whether vWF-levels among blood types has a clinical implication with respect to bleeding. One retrospective study 24 investigating 15,857 patients undergoing a variety of elective surgical procedures, found no effect of ABO blood type on surgical bleeding. This finding was supported by a study from 2013 that found no association between transfusion requirements and ABO blood type in 1050 propensitymatched O and non-O patients undergoing elective extensive spine-surgery. 15 However, a very recent study 18 reported an increased Notably, we found that late transfusion of blood products displayed a higher ratio of FFP and PLT to RBC, indicating that these late post-operative transfusions were administered in patients suspected for coagulopathy. This pattern was comparable in both blood type groups, indicating no difference in suspected coagulopathy across ABO blood group.
There are several limitations to the study. Since this was a retrospective study with a limited sample size, we need to consider the risk of residual confounding and type II error. To acknowledge this, more large-scale, multicenter prospective studies are needed. It has been suggested that the highest activity of factor VIII and vWF is observed in genotype A 1 A/A 1 B/BB, intermediate in A 1 O/BO, and the lowest activity in O/O. 3 We only assessed the phenotype of patients, which could lower the observed effect. No other blood type antigens or the level of vWF were examined in the current study. The exclusion criteria may have introduced a selection bias: if the use of antiplatelet or anticoagulant therapy is associated with thrombotic diseases, patients with a prothrombotic blood type may be more likely to receive medical therapy-however, we saw a proportional reduction of groups throughout identification of the study populations with no apparent selection bias. Furthermore, we have not considered the use of tranexamic acid or the possible haemodilution happening when resuscitating patients with "thin" fluids i.e. crystalloids and colloids. Finally, TEG/ROTEM-monitored transfusion has been a possibility at the hospital since 2012, but we did not include this potential confounder in our analysis, as the proportion of patients monitored by this is extremely low, especially in the initial years after introduction of this test.
In conclusion, we found no association between type O and transfusions in patients undergoing major emergency abdominal surgery. Abbreviations: ASA = American Society of Anaesthesiology physical status classification system; CCI = Charlson comorbidity index. Official recommendations for alcohol consumption are < 7 units/week for women, < 14 units/week for men (1 unit = 12 grams of alcohol).
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